Searchable abstracts of presentations at key conferences in endocrinology

ea0034p139 | Clinical practice/governance and case reports | SFEBES2014

Jumping the gun: an audit of adrenal biopsies in a tertiary referral centre

Chortis Vasileios , Scordilis Kassiani , Arlt Wiebke , Crowley Rachel

New adrenal lesions discovered during cross-sectional abdominal imaging pose an increasingly common diagnostic challenge; their initial management should focus on the exclusion of malignancy and autonomous hormone excess. The role of adrenal biopsies in this context is limited and pathologists often struggle to differentiate benign from malignant adrenal tissue even when analysing the entire tumour specimen. Guidelines recommend that adrenal biopsy should only be considered if...

ea0025p80 | Clinical biochemistry | SFEBES2011

Targets for improvement of care for thyroid carcinoma patients in the multidisciplinary setting

Lowney Aoife , Crowley Rachel , O'Halloran Domhnall , Tuthill Antoinette

The British Thyroid Association recommends that a specialist multidisciplinary team (MDT) is responsible for thyroid cancer management. In accordance with this recommendation, a team was formed to manage thyroid carcinoma in a tertiary referral centre. The team included endocrinology, general surgery, ENT, cytology, radiology and radiation oncology consultants.This audit was performed to assess management of thyroid carcinoma before the establishment of ...

ea0021p206 | Endocrine tumours and neoplasia | SFEBES2009

Case report: multiple endocrine neoplasia type 2a and hereditary haemorrhagic telangiectasia presenting consecutively in a single patient

Hussein Omer , Crowley Rachel , Sheahan Patrick , Brady Adrian , Tuthill Antoinette

Multiple endocrine neoplasia type 2a (MEN 2a) is an autosomal dominant disorder with an incidence of ~1 in 30 000 of the population. It is characterized by medullary thyroid cancer (MTC), benign or malignant phaeochromocytomas, and parathyroid hyperplasia or tumours.Hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu syndrome), is also an autosomal dominant disorder; this condition occurs with an incidence of ~1–2 per 100 000 of the population....

ea0011p71 | Clinical case reports | ECE2006

Adipsic diabetes insipidus following pituitary surgery for a macroprolactinoma

Sherlock M , Agha A , Smith D , Crowley R , Thompson C

Adipsic diabetes insipidus (ADI) is a rare condition which has been reported following clipping of anterior communicating artery aneurysms, craniopharyngioma and brain trauma, but not with pituitary adenoma. We report a case of ADI following surgery for a pituitary macroprolactinoma. A 14-year-old boy presented with bitemporal hemianopia due to a large macroprolactinoma. Two debulking surgeries were performed without the development of diabetes insipidus. Following a third rad...

ea0074oc9 | Oral Communications | SFENCC2021

Cardiac arrhythmia and ischaemic stroke in a young man with Resistance to Thyroid Hormone beta

Hannon Anne Marie , Kinsella Justin , Crowley Rachel , Moran Carla

Case history: A 42 year old male teacher presented to the emergency department with an acute right MCA infarct, on a background of paroxysmal atrial fibrillation/flutter and recurrent supraventricular tachycardia. He had chronic palpitations, with previous failed cardiac ablation. He had no other medical history, specifically, no history of ear infections or learning difficulties. There was no known family history of thyroid dysfunction. Previous TSH levels (no FT4 measurement...

ea0081p220 | Thyroid | ECE2022

Alpelisib-induced thyroiditis in a patient with metastatic breast carcinoma

Prem Kumar Anusha , Flynn Calvin , J Higgins Michaela , K Crowley Rachel , O'Shea Donal , Garrahy Aoife

Background: Alpelisib is a novel phosphotidylinositol 3-kinase (PI3K) inhibitor which, in combination with fulvestrant, has been shown to increase progression-free survival in patients with HR+/HER2-/PI3KCA mutated advanced breast cancer[1]. Hyperglycaemia, including alpelisib-induced diabetic ketoacidosis is a known adverse effect, along with rash, diarrhoea and stomatitis. No other associated endocrinopathy has been reported to date. Case presentation: We present th...

ea0049ep259 | Calcium & Vitamin D metabolism | ECE2017

Vitamin D prescribing bias in liver transplant referrals

Gan KJ , O'Sullivan Niamh , Hanley Bernadette , Armstrong Paul , Kilbane Mark , Houlihan Diarmaid , Crowley Rachel

Vitamin D (VD) deficiency (25 OHD < 50 nmol/l) is common is chronic liver disease at 64%–92% regardless of aetiology. The only guidelines for routine VD supplementation are for cholestatic (C) liver disease; a population considered being at high risk of low bone mineral density (BMD). BMD decreases further following orthotopic liver transplant (OLT). To assess VD intake in an at risk population, retrospective analysis of intake was performed in OLT patients with C liv...

ea0049ep430 | Diabetes (to include epidemiology, pathophysiology) | ECE2017

Endocrine factors associated with postprandial hypoglycaemia in patients with cystic fibrosis: a pilot study

Elamin Yasir , Crowley Rachel , Mckone ED , Twomey Patrick , Hatton Siobhan , Martin-Grace Julie , Kearns S

Postprandial hypoglycaemia in patients with cystic fibrosis (PWCF) is frequently reported but poorly understood. The aim of this pilot study was to investigate the aetiology of postprandial hypoglycaemia in PWCF. Serum cortisol, insulin and C-Peptide were measured at the 2 hour timepoint of the annual glucose tolerance test in 32 PWCF not known to have CF-related diabetes. Hypoglycaemia was defined as glucose < 3.3 mmol/l. Patients were classified as Normal glucose toleran...

ea0034oc6.1 | Clinical | SFEBES2014

Adverse outcome in glucocorticoid induced adrenal suppression; an analysis of short synacthen tests in 2782 patients

Chapman Matthew , Argese Nicola , Mani Dhanasekaran , Dabhi Vijay , Boot Christopher , Crowley Rachel , Stewart Paul , Tomlinson Jeremy

2–3% of the UK population are prescribed glucocorticoid (GC) therapy and their adverse effects contribute to a significant health burden. Suppression of endogenous GC secretion is a recognized complication of therapy, but the magnitude of the problem, together with its clinical consequences have not been determined. We conducted a retrospective study across all specialties in a large secondary–tertiary care center identifying 2782 patients who underwent 3666 250 &#95...

ea0034p272 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Liver fibrosis is common in Alstrom syndrome and can be identified using non-invasive tests

Hazlehurst Jonathan , Armstrong Matthew , Hodgkiss Jayne , Crowley Rachel , Geberhiwot Tarekegn , Newsome Phillip , Tomlinson Jeremy

Alstrom syndrome is an autosomal recessive ciliopathy that is characterised by increased body mass index, type 2 diabetes, retinal dystrophy, sensorineural hearing loss, cardiac fibrosis, and chronic kidney disease. Non-alcoholic fatty liver disease (NAFLD) in Alstrom patients ranges from simple steatosis, steatohepatitis and ultimately to fibrosis and cirrhosis. Nafld fibrosis score (http://nalfdscore.com/), enhanced liver fibrosis (ELF)-panel blood tests and Fibroscans are n...